Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125531271 | 12553127 | 1 | I | 2010 | 20160708 | 20160713 | 20160713 | EXP | BR-ELI_LILLY_AND_COMPANY-BR201607003148 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160713 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125531271 | 12553127 | 1 | PS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 50 IU, EACH MORNING | U | U | 18780 | 50 | IU | INJECTION | QD | ||||
| 125531271 | 12553127 | 2 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 20 IU, QD | U | U | 18780 | 20 | IU | INJECTION | QD | ||||
| 125531271 | 12553127 | 3 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 20 IU, EACH EVENING | U | U | 18780 | 20 | IU | INJECTION | QD | ||||
| 125531271 | 12553127 | 4 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 50 IU, EACH MORNING | C589028 | 0 | 50 | IU | INJECTION | QD | |||||
| 125531271 | 12553127 | 5 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 20 IU, QD | C589028 | 0 | 20 | IU | INJECTION | QD | |||||
| 125531271 | 12553127 | 6 | SS | HUMULIN N | INSULIN HUMAN | 1 | Subcutaneous | 20 IU, EACH EVENING | C589028 | 0 | 20 | IU | INJECTION | QD | |||||
| 125531271 | 12553127 | 7 | C | NESINA | ALOGLIPTIN BENZOATE | 1 | Unknown | 25 MG, UNKNOWN | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125531271 | 12553127 | 1 | Product used for unknown indication |
| 125531271 | 12553127 | 4 | Product used for unknown indication |
| 125531271 | 12553127 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125531271 | 12553127 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125531271 | 12553127 | Blood glucose increased | |
| 125531271 | 12553127 | Breast cancer | |
| 125531271 | 12553127 | Injection site pain | |
| 125531271 | 12553127 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125531271 | 12553127 | 1 | 1993 | 0 | ||
| 125531271 | 12553127 | 2 | 1993 | 0 | ||
| 125531271 | 12553127 | 3 | 1993 | 0 |